Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Ryu

Showing results (571-580 of 622) with videos related to

Pageof 63
Sort By:
Breast (Edinburgh, Scotland)|September 30, 2022
Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/nipple-sparing mastectomyNalee Kim, Won Park, Won Kyung Cho, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 14, 2026
Clinicopathologic characteristics and lymph node status in the NAUTILUS clinical trial:KBCSG-21Jai Min Ryu, Han-Byoel Lee, Wonshik Han, et al.
Cancer Research and Treatment|September 4, 2025
Long-Term Prognostic Value and Analytical Parameters of the Next-Generation Sequencing-Based Multigene Assay in Hormone Receptor-Positive, HER2-Negative Breast CancerHyunji Kim, Jiwon Koh, Hyunwoo Lee, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 15, 2025
Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of viewWoong Ki Park, Seok Jin Nam, Seok Won Kim, et al.
Journal of Breast Cancer|January 17, 2024
Oncologic Outcomes of Immediate Breast Reconstruction in the Setting of Neoadjuvant Chemotherapy: A Long-term Follow-up Study of a Matched CohortDong Seung Shin, Yoon Ju Bang, Joon Young Choi, et al.
Breast Cancer Research : BCR|April 10, 2026
Contributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11)Seon-Hi Shin, Sung Gwe Ahn, Jai Min Ryu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 25, 2025
Re-evaluating the necessity of removing residual calcifications detected after surgery in HR-/HER2+ breast cancer with pathologic complete responseCho Eun Lee, Seok Jin Nam, Seok Won Kim, et al.
Breast (Edinburgh, Scotland)|November 4, 2023
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancerNalee Kim, Ji-Yeon Kim, Won Park, et al.
Journal of Korean Medical Science|December 4, 2018
Current Status of Pediatric Critical Care in Korea: Results of 2015 National SurveyJong-Seo Yoon, Won Kyoung Jhang, Yu Hyeon Choi, et al.
American Journal of Cancer Research|October 12, 2020
Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancerJunyoung Choi, Hee Jin Lee, Shinkyo Yoon, et al.
Pageof 63

Showing results (571-580 of 622) with videos related to

Sort By:
Pageof 63
Breast (Edinburgh, Scotland)|September 30, 2022
Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/nipple-sparing mastectomyNalee Kim, Won Park, Won Kyung Cho, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 14, 2026
Clinicopathologic characteristics and lymph node status in the NAUTILUS clinical trial:KBCSG-21Jai Min Ryu, Han-Byoel Lee, Wonshik Han, et al.
Cancer Research and Treatment|September 4, 2025
Long-Term Prognostic Value and Analytical Parameters of the Next-Generation Sequencing-Based Multigene Assay in Hormone Receptor-Positive, HER2-Negative Breast CancerHyunji Kim, Jiwon Koh, Hyunwoo Lee, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 15, 2025
Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of viewWoong Ki Park, Seok Jin Nam, Seok Won Kim, et al.
Journal of Breast Cancer|January 17, 2024
Oncologic Outcomes of Immediate Breast Reconstruction in the Setting of Neoadjuvant Chemotherapy: A Long-term Follow-up Study of a Matched CohortDong Seung Shin, Yoon Ju Bang, Joon Young Choi, et al.
Breast Cancer Research : BCR|April 10, 2026
Contributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11)Seon-Hi Shin, Sung Gwe Ahn, Jai Min Ryu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 25, 2025
Re-evaluating the necessity of removing residual calcifications detected after surgery in HR-/HER2+ breast cancer with pathologic complete responseCho Eun Lee, Seok Jin Nam, Seok Won Kim, et al.
Breast (Edinburgh, Scotland)|November 4, 2023
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancerNalee Kim, Ji-Yeon Kim, Won Park, et al.
Journal of Korean Medical Science|December 4, 2018
Current Status of Pediatric Critical Care in Korea: Results of 2015 National SurveyJong-Seo Yoon, Won Kyoung Jhang, Yu Hyeon Choi, et al.
American Journal of Cancer Research|October 12, 2020
Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancerJunyoung Choi, Hee Jin Lee, Shinkyo Yoon, et al.
Pageof 63